Dr. Munshi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3800 Reservoir Rd NW
Washington, DC 20007Phone+1 202-444-3736Fax+1 202-444-0939
Education & Training
- Rutgers Health/Robert Wood Johnson Medical SchoolFellowship, Hematology and Medical Oncology, 2011 - 2014
- Cooper Medical School of Rowan University/Cooper University HospitalResidency, Internal Medicine, 2008 - 2011
- KJ Somaiya Medical CollegeClass of 2006
Certifications & Licensure
- NJ State Medical License 2012 - 2025
- DC State Medical License 2015 - 2024
- PA State Medical License 2023 - 2024
- MD State Medical License 2017 - 2023
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study of TAK-007 in Adults With Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL) Start of enrollment: 2021 Nov 12
Roles: Principal Investigator
Publications & Presentations
PubMed
- 262 citationsAxicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial.Caron A Jacobson, Julio C Chavez, Alison R Sehgal, Basem M William, Javier Munoz
The Lancet. Oncology. 2022-01-01 - 15 citationsImpact of second primary malignancy post-autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis.Brittany Knick Ragon, Mithun Vinod Shah, Anita D'Souza, Noel Estrada-Merly, Lohith Gowda
Blood Advances. 2023-06-27 - 24 citationsThree-year follow-up analysis of axicabtagene ciloleucel in relapsed/refractory indolent non-Hodgkin lymphoma (ZUMA-5).Sattva S Neelapu, Julio C Chavez, Alison R Sehgal, Narendranath Epperla, Matthew Ulrickson
Blood. 2024-02-08
Abstracts/Posters
- Factors Associated with Subsequent Cancers in Patients with Moderate or Severe Chronic Graft-Versus-Host Disease after Transplant for Hematologic MalignancyPashna N. Munshi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Sustained Hematopoietic Recovery after Salvage Autologous Stem Cell Transplants after Long Term Storage of Cryopreserved Hematopoietic Progenitor Stem Cells (HPSC)Pashna N. Munshi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
- 'Good Things Can Happen': Experimental Treatment Helps Maryland Woman Beat LymphomaJanuary 11th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: